Colorado Initiative in Molecular Biotechnology to Support BIC Commercialization
Boulder Innovation Center Bioscience Program
Gets Boost From ¶¶ÒõÂÃÐÐÉä
Ìý
BOULDER, Colo. (Nov. 5, 2009) – The Boulder Innovation Center (BIC), as part its mission to commercialize scientific inventions developed at the University of Colorado, has received financial support from ¶¶ÒõÂÃÐÐÉä-Boulder’s CIMB (Colorado Initiative in Molecular Biotechnology) to expand its Bioscience Program.
Tim Prodanovich, BIC Bioscience Program Manager, will be expanding his work with CIMB faculty to identify promising commercial applications related to inventions resulting from their research. CIMB is lead by Nobel Laureate and ¶¶ÒõÂÃÐÐÉä Distinguished Professor Tom Cech and Director Dr. Leslie Leinwand. Prodanovich will support commercialization programs in coordination with the CIMB and ¶¶ÒõÂÃÐÐÉä’s Tech Transfer Office, focusing on Proof-of-Concept Proposal development; business advisor, mentor and executive team recruitment; feasibility studies and business planning; and capital formation strategies.
(Originally published in Denver Business Journal)